GDF15 enhances the tumor-initiating and self-renewal potential of myeloma cells [18], contributes to drug resistance in both stroma-dependent/independent MM cells [14, 15], and promotes osteoclast differentiation while inhibits osteoblast differentiation [17]. The gene discussed is GDF15; the disease is plasma cell myeloma.